UniProt ID | TCPD_HUMAN | |
---|---|---|
UniProt AC | P50991 | |
Protein Name | T-complex protein 1 subunit delta | |
Gene Name | CCT4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 539 | |
Subcellular Localization | Cytoplasm . Melanosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, cilium basal body . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MPENVAPRSGATAGAAGGRGKGAYQDRDKPAQIRFSNISAAKAVADAIRTSLGPKGMDKMIQDGKGDVTITNDGATILKQMQVLHPAARMLVELSKAQDIEAGDGTTSVVIIAGSLLDSCTKLLQKGIHPTIISESFQKALEKGIEILTDMSRPVELSDRETLLNSATTSLNSKVVSQYSSLLSPMSVNAVMKVIDPATATSVDLRDIKIVKKLGGTIDDCELVEGLVLTQKVSNSGITRVEKAKIGLIQFCLSAPKTDMDNQIVVSDYAQMDRVLREERAYILNLVKQIKKTGCNVLLIQKSILRDALSDLALHFLNKMKIMVIKDIEREDIEFICKTIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGKLLKITGCASPGKTVTIVVRGSNKLVIEEAERSIHDALCVIRCLVKKRALIAGGGAPEIELALRLTEYSRTLSGMESYCVRAFADAMEVIPSTLAENAGLNPISTVTELRNRHAQGEKTAGINVRKGGISNILEELVVQPLLVSVSALTLATETVRSILKIDDVVNTR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Methylation | MPENVAPRSGATAGA CCCCCCCCCCCCCCC | 37.68 | - | |
9 | Phosphorylation | PENVAPRSGATAGAA CCCCCCCCCCCCCCC | 31.55 | 25159151 | |
19 | Methylation | TAGAAGGRGKGAYQD CCCCCCCCCCCCCCC | 42.61 | 24129315 | |
21 | Acetylation | GAAGGRGKGAYQDRD CCCCCCCCCCCCCCC | 38.72 | - | |
21 | Methylation | GAAGGRGKGAYQDRD CCCCCCCCCCCCCCC | 38.72 | - | |
24 | Phosphorylation | GGRGKGAYQDRDKPA CCCCCCCCCCCCCCC | 21.44 | 25367160 | |
27 | Methylation | GKGAYQDRDKPAQIR CCCCCCCCCCCCCEE | 38.02 | - | |
29 | Acetylation | GAYQDRDKPAQIRFS CCCCCCCCCCCEEEC | 43.05 | 25953088 | |
29 | Ubiquitination | GAYQDRDKPAQIRFS CCCCCCCCCCCEEEC | 43.05 | 33845483 | |
36 | Phosphorylation | KPAQIRFSNISAAKA CCCCEEECCHHHHHH | 24.33 | 30266825 | |
40 | Ubiquitination | IRFSNISAAKAVADA EEECCHHHHHHHHHH | 14.80 | 21890473 | |
42 | Ubiquitination | FSNISAAKAVADAIR ECCHHHHHHHHHHHH | 43.01 | 23000965 | |
49 | Methylation | KAVADAIRTSLGPKG HHHHHHHHHCCCCCC | 21.71 | - | |
54 | Ubiquitination | AIRTSLGPKGMDKMI HHHHCCCCCCHHHCC | 35.01 | 21890473 | |
55 | 2-Hydroxyisobutyrylation | IRTSLGPKGMDKMIQ HHHCCCCCCHHHCCC | 66.13 | - | |
55 | Acetylation | IRTSLGPKGMDKMIQ HHHCCCCCCHHHCCC | 66.13 | 23749302 | |
55 | Succinylation | IRTSLGPKGMDKMIQ HHHCCCCCCHHHCCC | 66.13 | 23954790 | |
55 | Ubiquitination | IRTSLGPKGMDKMIQ HHHCCCCCCHHHCCC | 66.13 | 29967540 | |
59 | 2-Hydroxyisobutyrylation | LGPKGMDKMIQDGKG CCCCCHHHCCCCCCC | 29.07 | - | |
59 | Ubiquitination | LGPKGMDKMIQDGKG CCCCCHHHCCCCCCC | 29.07 | 23000965 | |
60 | Sulfoxidation | GPKGMDKMIQDGKGD CCCCHHHCCCCCCCC | 2.64 | 30846556 | |
65 | 2-Hydroxyisobutyrylation | DKMIQDGKGDVTITN HHCCCCCCCCEEEEC | 61.29 | - | |
65 | Acetylation | DKMIQDGKGDVTITN HHCCCCCCCCEEEEC | 61.29 | 26051181 | |
65 | Ubiquitination | DKMIQDGKGDVTITN HHCCCCCCCCEEEEC | 61.29 | 23000965 | |
65 (in isoform 2) | Phosphorylation | - | 61.29 | 30175587 | |
71 | Phosphorylation | GKGDVTITNDGATIL CCCCEEEECCHHHHH | 20.21 | 25690035 | |
76 | Phosphorylation | TITNDGATILKQMQV EEECCHHHHHHHHHH | 32.16 | 25690035 | |
79 | Acetylation | NDGATILKQMQVLHP CCHHHHHHHHHHHCH | 39.61 | 25953088 | |
79 | Ubiquitination | NDGATILKQMQVLHP CCHHHHHHHHHHHCH | 39.61 | 23000965 | |
81 | Sulfoxidation | GATILKQMQVLHPAA HHHHHHHHHHHCHHH | 2.58 | 30846556 | |
92 | Ubiquitination | HPAARMLVELSKAQD CHHHHHHHHHHHHCC | 5.20 | 23000965 | |
95 | Phosphorylation | ARMLVELSKAQDIEA HHHHHHHHHHCCCCC | 16.67 | - | |
96 | Ubiquitination | RMLVELSKAQDIEAG HHHHHHHHHCCCCCC | 63.79 | 23000965 | |
101 | Ubiquitination | LSKAQDIEAGDGTTS HHHHCCCCCCCCCEE | 55.69 | 21890473 | |
109 | Acetylation | AGDGTTSVVIIAGSL CCCCCEEEEEEEHHH | 3.17 | 19608861 | |
109 | Ubiquitination | AGDGTTSVVIIAGSL CCCCCEEEEEEEHHH | 3.17 | 16196087 | |
113 | Ubiquitination | TTSVVIIAGSLLDSC CEEEEEEEHHHHHHH | 7.15 | 22505724 | |
114 | Ubiquitination | TSVVIIAGSLLDSCT EEEEEEEHHHHHHHH | 14.39 | 21890473 | |
120 | Glutathionylation | AGSLLDSCTKLLQKG EHHHHHHHHHHHHCC | 3.77 | 22555962 | |
122 | Ubiquitination | SLLDSCTKLLQKGIH HHHHHHHHHHHCCCC | 52.07 | 23000965 | |
126 | 2-Hydroxyisobutyrylation | SCTKLLQKGIHPTII HHHHHHHCCCCHHHH | 60.86 | - | |
126 | Acetylation | SCTKLLQKGIHPTII HHHHHHHCCCCHHHH | 60.86 | 25953088 | |
126 | Ubiquitination | SCTKLLQKGIHPTII HHHHHHHCCCCHHHH | 60.86 | 23000965 | |
139 | 2-Hydroxyisobutyrylation | IISESFQKALEKGIE HHCHHHHHHHHHCCH | 53.59 | - | |
139 | Acetylation | IISESFQKALEKGIE HHCHHHHHHHHHCCH | 53.59 | 23749302 | |
139 | Methylation | IISESFQKALEKGIE HHCHHHHHHHHHCCH | 53.59 | 19608861 | |
139 | Ubiquitination | IISESFQKALEKGIE HHCHHHHHHHHHCCH | 53.59 | 16196087 | |
143 | Ubiquitination | SFQKALEKGIEILTD HHHHHHHHCCHHHHC | 67.07 | 22505724 | |
151 | Sulfoxidation | GIEILTDMSRPVELS CCHHHHCCCCCCCCC | 2.85 | 30846556 | |
158 | Phosphorylation | MSRPVELSDRETLLN CCCCCCCCCHHHHHH | 22.55 | 25627689 | |
160 | Methylation | RPVELSDRETLLNSA CCCCCCCHHHHHHHH | 35.11 | - | |
170 | Phosphorylation | LLNSATTSLNSKVVS HHHHHCHHHHHHHHH | 22.62 | 19664995 | |
177 | Phosphorylation | SLNSKVVSQYSSLLS HHHHHHHHHHHHHHC | 26.79 | 23186163 | |
179 | Phosphorylation | NSKVVSQYSSLLSPM HHHHHHHHHHHHCCC | 7.85 | 23186163 | |
179 | Ubiquitination | NSKVVSQYSSLLSPM HHHHHHHHHHHHCCC | 7.85 | 27667366 | |
180 | Phosphorylation | SKVVSQYSSLLSPMS HHHHHHHHHHHCCCC | 13.58 | 20068231 | |
181 | Phosphorylation | KVVSQYSSLLSPMSV HHHHHHHHHHCCCCH | 28.53 | 20068231 | |
183 | Ubiquitination | VSQYSSLLSPMSVNA HHHHHHHHCCCCHHH | 6.12 | 29967540 | |
184 | Phosphorylation | SQYSSLLSPMSVNAV HHHHHHHCCCCHHHH | 24.69 | 20068231 | |
187 | Phosphorylation | SSLLSPMSVNAVMKV HHHHCCCCHHHHHHH | 18.66 | 20068231 | |
199 | Phosphorylation | MKVIDPATATSVDLR HHHCCHHHCCCCCHH | 35.54 | 21406692 | |
201 | Phosphorylation | VIDPATATSVDLRDI HCCHHHCCCCCHHHH | 25.57 | 29255136 | |
202 | Neddylation | IDPATATSVDLRDIK CCHHHCCCCCHHHHH | 15.92 | 32015554 | |
202 | Phosphorylation | IDPATATSVDLRDIK CCHHHCCCCCHHHHH | 15.92 | 29255136 | |
202 | Ubiquitination | IDPATATSVDLRDIK CCHHHCCCCCHHHHH | 15.92 | 21963094 | |
206 | Methylation | TATSVDLRDIKIVKK HCCCCCHHHHHHHHH | 38.86 | - | |
209 | Succinylation | SVDLRDIKIVKKLGG CCCHHHHHHHHHCCC | 45.82 | 23954790 | |
209 | Sumoylation | SVDLRDIKIVKKLGG CCCHHHHHHHHHCCC | 45.82 | - | |
209 | Ubiquitination | SVDLRDIKIVKKLGG CCCHHHHHHHHHCCC | 45.82 | 27667366 | |
213 | Acetylation | RDIKIVKKLGGTIDD HHHHHHHHCCCCCCC | 41.28 | 25953088 | |
213 | Ubiquitination | RDIKIVKKLGGTIDD HHHHHHHHCCCCCCC | 41.28 | 29967540 | |
217 | O-linked_Glycosylation | IVKKLGGTIDDCELV HHHHCCCCCCCCEEE | 21.31 | 23301498 | |
217 | Phosphorylation | IVKKLGGTIDDCELV HHHHCCCCCCCCEEE | 21.31 | 30624053 | |
221 | Glutathionylation | LGGTIDDCELVEGLV CCCCCCCCEEEEEEE | 3.75 | 22555962 | |
221 | S-palmitoylation | LGGTIDDCELVEGLV CCCCCCCCEEEEEEE | 3.75 | 26865113 | |
232 | Acetylation | EGLVLTQKVSNSGIT EEEEEEEECCCCCCC | 42.25 | 25953088 | |
232 | Neddylation | EGLVLTQKVSNSGIT EEEEEEEECCCCCCC | 42.25 | 32015554 | |
232 | Ubiquitination | EGLVLTQKVSNSGIT EEEEEEEECCCCCCC | 42.25 | 21963094 | |
234 | Phosphorylation | LVLTQKVSNSGITRV EEEEEECCCCCCCEE | 32.11 | 25159151 | |
236 | Phosphorylation | LTQKVSNSGITRVEK EEEECCCCCCCEEEE | 24.86 | 25159151 | |
239 | Phosphorylation | KVSNSGITRVEKAKI ECCCCCCCEEEEEEE | 31.99 | 29514088 | |
243 | Ubiquitination | SGITRVEKAKIGLIQ CCCCEEEEEEECEEH | 52.72 | 29967540 | |
245 | Ubiquitination | ITRVEKAKIGLIQFC CCEEEEEEECEEHHH | 48.66 | - | |
252 | Glutathionylation | KIGLIQFCLSAPKTD EECEEHHHHCCCCCC | 1.36 | 22555962 | |
252 | S-palmitoylation | KIGLIQFCLSAPKTD EECEEHHHHCCCCCC | 1.36 | 29575903 | |
254 | Phosphorylation | GLIQFCLSAPKTDMD CEEHHHHCCCCCCCC | 43.64 | 21712546 | |
258 | Acetylation | FCLSAPKTDMDNQIV HHHCCCCCCCCCCEE | 35.18 | 19608861 | |
258 | Phosphorylation | FCLSAPKTDMDNQIV HHHCCCCCCCCCCEE | 35.18 | 21945579 | |
258 | Ubiquitination | FCLSAPKTDMDNQIV HHHCCCCCCCCCCEE | 35.18 | 23000965 | |
260 | Sulfoxidation | LSAPKTDMDNQIVVS HCCCCCCCCCCEEEC | 6.71 | 30846556 | |
261 | Ubiquitination | SAPKTDMDNQIVVSD CCCCCCCCCCEEECC | 46.85 | 23000965 | |
262 | Ubiquitination | APKTDMDNQIVVSDY CCCCCCCCCEEECCH | 27.17 | 23000965 | |
263 | Ubiquitination | PKTDMDNQIVVSDYA CCCCCCCCEEECCHH | 26.11 | 21890473 | |
267 | Phosphorylation | MDNQIVVSDYAQMDR CCCCEEECCHHHHHH | 17.63 | 21945579 | |
269 | Nitration | NQIVVSDYAQMDRVL CCEEECCHHHHHHHH | 7.39 | - | |
269 | Phosphorylation | NQIVVSDYAQMDRVL CCEEECCHHHHHHHH | 7.39 | 23663014 | |
272 | Acetylation | VVSDYAQMDRVLREE EECCHHHHHHHHHHH | 2.43 | 19608861 | |
272 | Sulfoxidation | VVSDYAQMDRVLREE EECCHHHHHHHHHHH | 2.43 | 30846556 | |
272 | Ubiquitination | VVSDYAQMDRVLREE EECCHHHHHHHHHHH | 2.43 | 21963094 | |
274 | Methylation | SDYAQMDRVLREERA CCHHHHHHHHHHHHH | 24.83 | - | |
282 | Nitration | VLREERAYILNLVKQ HHHHHHHHHHHHHHH | 16.50 | - | |
282 | Phosphorylation | VLREERAYILNLVKQ HHHHHHHHHHHHHHH | 16.50 | 28442448 | |
288 | Acetylation | AYILNLVKQIKKTGC HHHHHHHHHHHHHCC | 49.85 | 19608861 | |
288 | Malonylation | AYILNLVKQIKKTGC HHHHHHHHHHHHHCC | 49.85 | 26320211 | |
288 | Ubiquitination | AYILNLVKQIKKTGC HHHHHHHHHHHHHCC | 49.85 | 23000965 | |
289 | Acetylation | YILNLVKQIKKTGCN HHHHHHHHHHHHCCC | 45.30 | 19608861 | |
289 | Ubiquitination | YILNLVKQIKKTGCN HHHHHHHHHHHHCCC | 45.30 | 33845483 | |
291 | Ubiquitination | LNLVKQIKKTGCNVL HHHHHHHHHHCCCEE | 41.61 | 23000965 | |
292 | Malonylation | NLVKQIKKTGCNVLL HHHHHHHHHCCCEEE | 52.35 | 26320211 | |
292 | Ubiquitination | NLVKQIKKTGCNVLL HHHHHHHHHCCCEEE | 52.35 | 23000965 | |
294 | Ubiquitination | VKQIKKTGCNVLLIQ HHHHHHHCCCEEEEE | 15.19 | 21890473 | |
295 | S-nitrosocysteine | KQIKKTGCNVLLIQK HHHHHHCCCEEEEEH | 3.73 | - | |
295 | S-nitrosylation | KQIKKTGCNVLLIQK HHHHHHCCCEEEEEH | 3.73 | 22178444 | |
295 | S-palmitoylation | KQIKKTGCNVLLIQK HHHHHHCCCEEEEEH | 3.73 | 29575903 | |
296 | Acetylation | QIKKTGCNVLLIQKS HHHHHCCCEEEEEHH | 28.90 | 19608861 | |
302 | 2-Hydroxyisobutyrylation | CNVLLIQKSILRDAL CCEEEEEHHHHHHHH | 32.25 | - | |
302 | Acetylation | CNVLLIQKSILRDAL CCEEEEEHHHHHHHH | 32.25 | 19608861 | |
302 | Ubiquitination | CNVLLIQKSILRDAL CCEEEEEHHHHHHHH | 32.25 | 21963094 | |
303 | Phosphorylation | NVLLIQKSILRDALS CEEEEEHHHHHHHHH | 15.52 | 24719451 | |
319 | 2-Hydroxyisobutyrylation | LALHFLNKMKIMVIK HHHHHHHHCCEEEEE | 43.66 | - | |
319 | Acetylation | LALHFLNKMKIMVIK HHHHHHHHCCEEEEE | 43.66 | 19608861 | |
319 | Ubiquitination | LALHFLNKMKIMVIK HHHHHHHHCCEEEEE | 43.66 | 21906983 | |
321 | 2-Hydroxyisobutyrylation | LHFLNKMKIMVIKDI HHHHHHCCEEEEECC | 29.29 | - | |
321 | Acetylation | LHFLNKMKIMVIKDI HHHHHHCCEEEEECC | 29.29 | 23749302 | |
321 | Malonylation | LHFLNKMKIMVIKDI HHHHHHCCEEEEECC | 29.29 | 26320211 | |
321 | Ubiquitination | LHFLNKMKIMVIKDI HHHHHHCCEEEEECC | 29.29 | 23503661 | |
326 | Acetylation | KMKIMVIKDIEREDI HCCEEEEECCCHHHH | 41.04 | 19608861 | |
337 | Glutathionylation | REDIEFICKTIGTKP HHHHHHHHHHHCCCC | 3.74 | 22555962 | |
342 | Ubiquitination | FICKTIGTKPVAHID HHHHHHCCCCCCCHH | 28.46 | 22817900 | |
343 | Ubiquitination | ICKTIGTKPVAHIDQ HHHHHCCCCCCCHHH | 32.08 | - | |
345 | Ubiquitination | KTIGTKPVAHIDQFT HHHCCCCCCCHHHHH | 6.88 | 27667366 | |
354 | Ubiquitination | HIDQFTADMLGSAEL CHHHHHHHHHCCHHH | 29.76 | 21963094 | |
365 | Ubiquitination | SAELAEEVNLNGSGK CHHHHHHHCCCCCCC | 8.11 | 21963094 | |
372 | Ubiquitination | VNLNGSGKLLKITGC HCCCCCCCEEEEEEE | 52.95 | 22817900 | |
375 | 2-Hydroxyisobutyrylation | NGSGKLLKITGCASP CCCCCEEEEEEECCC | 48.97 | - | |
375 | Acetylation | NGSGKLLKITGCASP CCCCCEEEEEEECCC | 48.97 | 23236377 | |
375 | Malonylation | NGSGKLLKITGCASP CCCCCEEEEEEECCC | 48.97 | 26320211 | |
375 | Ubiquitination | NGSGKLLKITGCASP CCCCCEEEEEEECCC | 48.97 | 27667366 | |
377 | Phosphorylation | SGKLLKITGCASPGK CCCEEEEEEECCCCC | 25.31 | 29396449 | |
379 | S-nitrosocysteine | KLLKITGCASPGKTV CEEEEEEECCCCCEE | 2.25 | - | |
379 | S-nitrosylation | KLLKITGCASPGKTV CEEEEEEECCCCCEE | 2.25 | 22178444 | |
381 | Phosphorylation | LKITGCASPGKTVTI EEEEEECCCCCEEEE | 37.96 | 25159151 | |
384 | Acetylation | TGCASPGKTVTIVVR EEECCCCCEEEEEEC | 43.11 | 26051181 | |
384 | Ubiquitination | TGCASPGKTVTIVVR EEECCCCCEEEEEEC | 43.11 | 21963094 | |
385 | Phosphorylation | GCASPGKTVTIVVRG EECCCCCEEEEEECC | 28.88 | 28450419 | |
387 | Phosphorylation | ASPGKTVTIVVRGSN CCCCCEEEEEECCCC | 17.18 | 23312004 | |
393 | Phosphorylation | VTIVVRGSNKLVIEE EEEEECCCCCEEECH | 21.89 | 20860994 | |
395 | 2-Hydroxyisobutyrylation | IVVRGSNKLVIEEAE EEECCCCCEEECHHH | 45.92 | - | |
395 | Acetylation | IVVRGSNKLVIEEAE EEECCCCCEEECHHH | 45.92 | 23954790 | |
395 | Malonylation | IVVRGSNKLVIEEAE EEECCCCCEEECHHH | 45.92 | 26320211 | |
395 | Ubiquitination | IVVRGSNKLVIEEAE EEECCCCCEEECHHH | 45.92 | 21906983 | |
410 | S-nitrosocysteine | RSIHDALCVIRCLVK HHHHHHHHHHHHHHH | 2.28 | - | |
410 | Glutathionylation | RSIHDALCVIRCLVK HHHHHHHHHHHHHHH | 2.28 | 22555962 | |
410 | S-nitrosylation | RSIHDALCVIRCLVK HHHHHHHHHHHHHHH | 2.28 | 19483679 | |
442 | Phosphorylation | RLTEYSRTLSGMESY HHHHHHHHHCCHHHH | 21.23 | 26074081 | |
444 | Phosphorylation | TEYSRTLSGMESYCV HHHHHHHCCHHHHHH | 35.17 | 14702039 | |
446 | Sulfoxidation | YSRTLSGMESYCVRA HHHHHCCHHHHHHHH | 2.51 | 30846556 | |
448 | Phosphorylation | RTLSGMESYCVRAFA HHHCCHHHHHHHHHH | 18.23 | 28442448 | |
449 | Phosphorylation | TLSGMESYCVRAFAD HHCCHHHHHHHHHHH | 5.01 | 17360941 | |
450 | Glutathionylation | LSGMESYCVRAFADA HCCHHHHHHHHHHHH | 2.02 | 22555962 | |
458 | Sulfoxidation | VRAFADAMEVIPSTL HHHHHHHHHHCHHHH | 4.32 | 30846556 | |
459 | Acetylation | RAFADAMEVIPSTLA HHHHHHHHHCHHHHH | 38.73 | 19608861 | |
459 | Ubiquitination | RAFADAMEVIPSTLA HHHHHHHHHCHHHHH | 38.73 | 27667366 | |
463 | Phosphorylation | DAMEVIPSTLAENAG HHHHHCHHHHHHHCC | 25.57 | 21406692 | |
464 | Phosphorylation | AMEVIPSTLAENAGL HHHHCHHHHHHHCCC | 25.32 | 21406692 | |
475 | Phosphorylation | NAGLNPISTVTELRN HCCCCCCCHHHHHHH | 20.34 | 21406692 | |
476 | Phosphorylation | AGLNPISTVTELRNR CCCCCCCHHHHHHHH | 31.97 | 21406692 | |
478 | Phosphorylation | LNPISTVTELRNRHA CCCCCHHHHHHHHHC | 29.41 | 21406692 | |
489 | 2-Hydroxyisobutyrylation | NRHAQGEKTAGINVR HHHCCCCCCCCEECC | 50.96 | - | |
489 | Acetylation | NRHAQGEKTAGINVR HHHCCCCCCCCEECC | 50.96 | 19608861 | |
489 | Ubiquitination | NRHAQGEKTAGINVR HHHCCCCCCCCEECC | 50.96 | 27667366 | |
501 | Ubiquitination | NVRKGGISNILEELV ECCCCCHHHHHHHHC | 22.54 | 23000965 | |
506 | Ubiquitination | GISNILEELVVQPLL CHHHHHHHHCHHHHH | 43.34 | 21890473 | |
528 | Phosphorylation | LATETVRSILKIDDV HHHHHHHHHHCHHHH | 28.12 | 24719451 | |
531 | 2-Hydroxyisobutyrylation | ETVRSILKIDDVVNT HHHHHHHCHHHHCCC | 42.28 | - | |
531 | Acetylation | ETVRSILKIDDVVNT HHHHHHHCHHHHCCC | 42.28 | 25953088 | |
531 | Succinylation | ETVRSILKIDDVVNT HHHHHHHCHHHHCCC | 42.28 | 23954790 | |
531 | Ubiquitination | ETVRSILKIDDVVNT HHHHHHHCHHHHCCC | 42.28 | 23000965 | |
538 | Phosphorylation | KIDDVVNTR------ CHHHHCCCC------ | 26.58 | 21815630 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPD_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPD_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TCPZ_HUMAN | CCT6A | physical | 22939629 | |
TCPG_HUMAN | CCT3 | physical | 22939629 | |
TCPH_HUMAN | CCT7 | physical | 22939629 | |
TCPE_HUMAN | CCT5 | physical | 22939629 | |
TCPQ_HUMAN | CCT8 | physical | 22939629 | |
TCPW_HUMAN | CCT6B | physical | 22939629 | |
XPO1_HUMAN | XPO1 | physical | 22939629 | |
TXNL1_HUMAN | TXNL1 | physical | 22939629 | |
TCPG_HUMAN | CCT3 | physical | 22863883 | |
TCPA_HUMAN | TCP1 | physical | 22863883 | |
SYVC_HUMAN | VARS | physical | 22863883 | |
VRK2_HUMAN | VRK2 | physical | 24298020 | |
CALX_HUMAN | CANX | physical | 26344197 | |
TCPB_HUMAN | CCT2 | physical | 26344197 | |
TCPH_HUMAN | CCT7 | physical | 26344197 | |
TCPQ_HUMAN | CCT8 | physical | 26344197 | |
DNJA4_HUMAN | DNAJA4 | physical | 26344197 | |
CH10_HUMAN | HSPE1 | physical | 26344197 | |
ECM29_HUMAN | KIAA0368 | physical | 26344197 | |
PDCL3_HUMAN | PDCL3 | physical | 26344197 | |
PRS7_HUMAN | PSMC2 | physical | 26344197 | |
TCPA_HUMAN | TCP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-139; LYS-288; LYS-302;LYS-319; LYS-326 AND LYS-489, AND MASS SPECTROMETRY. |